Clinical Trials & Research
Many of today's most effective standard treatments are based on the results of previous clinical studies, and many cancer patients are now living longer because of progress made through clinical trials. Clinical trials offer high quality cancer care and also allow patients the opportunity to advance scientific knowledge and help future patients.
Ongoing research is essential in the fight against cancer, and it is one of the major objectives of the Edwards Comprehensive Cancer Center.
Clinical trials currently available
| Code | Description |
|---|---|
| CA204-006 | A Phase 3, Randomized, Open Label trial of Lenalidomide/dexamethasone With or without Elotuzumab in Subjects With Previously Untreated Multiple Myeloma. |
| E2905 | Randomized Phase III Trial Comparing the Frequency of Major Erythroid Response (MER) to Treatment with Lenalidomide (Revlimid) Alone and in Combination with Epoetin Alfa (Procrit) in Subjects with Low- or Intermediate-1 Risk MDS and Symptomatic Anemia. |
- Page last updated: Jan 4, 2013
-
